K2 Therapeutics

SHANGHAI, China, June 22, 2026 CureGene Pharmaceutical has announced the successful dosing of the first participant in the U.S....

BOSTON, Singapore and Hong Kong, June 22, 2026 Antengene Corporation Limited has announced a landmark strategic licensing agreement with...